The World Health Organization price weight loss and warns: the risks are still in place

The World Health Organization said this week that a new category of weight loss medicine developed by “Novo Nordisk” and “Eli Lily” opened the door for the possibility of ending the obesity epidemic with other interventions, but it expressed “its concern” of the “risks”. “According to the organization, more than a billion people around the world are suffering from obesity, and there were 5 million obesity deaths in 2019 as it became almost more common in the whole world. In a joint opinion article published by the US medical magazine” Gama “, the chief scientist, Jeremy Ferrar, and his adviser, FranceSca Celiti, is the director of the organization, and is the director of the organization, Francesco said that the new drugs “are, the new drugs” have great change. ” The book’s book added that the combination of this could make a change with new medicine, but they expressed concern on how to use this medicine, known as commercial names, which are ‘Wigofi’, ‘Montgogo’, ‘Zipond’ and ‘Ozmbek’. The article acknowledged that although there is good evidence of the effectiveness of policies aimed at following healthy diets and regular physical activity, “it’s time to admit that she has not yet managed to treat obesity.”